CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.

Society / Forget Kennedy’s faux-populist, anti-science approach. The former FTC chair provides the real model of an ideal HHS ...

In this edition of The National Observer, we look at why pharmacy chains are closing — and what it means for areas that'll ...

Most of the 24 million people in Affordable Care Act health plans face a potential one-two punch next year — double-digit ...

Consumers face both rising premiums and falling subsidies next year in Obamacare plans, with insurers seeking increases to ...